The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline.
Read Also
- If You Invested $100 In This Stock 15 Years Ago, You Would Have $23,000 Today
- Here's How Much You Would Have Made Owning Blackstone Stock In The Last 10 Years
- Trump Vs. Biden: Former President Retakes Lead In 2024 Election Poll After Debate, More Voters See Incumbent As 'Too Old'
- Here's How Much You Would Have Made Owning Permian Resources Stock In The Last 5 Years
- Here's How Much $100 Invested In Amkor Tech 20 Years Ago Would Be Worth Today
- A Successful Partnership Hinges on Careful Planning and Execution. Here Are 7 Things You Need to Ensure Partnership Success.
- Nvidia's CEO Sold Stock for the First Time This Year and Netted the Most He Ever Has in a Single Month
- Biden Should Step Aside, Say Business Leaders Including Walmart Heir
- Wharton's Jeremy Siegel Implores Jerome Powell To Signal September Rate Cuts: 'We Are In A Slowing Economy'
- Craft Weed Company Bets On New Jersey Market, Now Owns 44% Of This State-Licensed Cultivator
Latest TheStreet
- Crypto hacks have doubled in 2024
- The best sun-protection items to pack for a cruise
- How Fourth of July at this national park ended in tragedy
- Walmart is selling a nearly $800 patio sectional set for only $548, and shoppers say it lasts 4+ years
- Amazon is selling a $200 Dehumidifier that shoppers call a 'game changer' for only $120
- Walmart Plus is now 50% off for a limited time — here's what you need to know before you buy
- What to expect on a cruise ship during a hurricane
- Delta makes big food change for second time after diverted flight
- Veteran fund manager offers striking assessment of bitcoin
- Inflation skews public perception of economy